Clinical Disease and Outcomes of Group B Streptococcus Bloodstream Infections at a Teaching Hospital in Saudi Arabia From 2015 to 2022

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2024 Mar 21

PMID 38510909

Authors

Nisreen Bajnaid

Reham Kaki

Affiliations

Soon will be listed here.

Abstract

Background Invasive disease due to group B (GBS) infection in adult males and nonpregnant females can cause various diseases, such as primary bacteremia, endocarditis, skin and soft tissue infection (SSTI), and meningitis. Especially in older people, invasive GBS infection has a high case fatality rate. In Saudi Arabia, little is known about the clinical signs and symptoms of GBS bacteremia and the associated risk factors and mortality rate. Methodology We performed a retrospective study at King Abdulaziz University Hospital in Jeddah, Saudi Arabia, a large tertiary hospital, to investigate clinical disease, potential risk factors, susceptibility patterns, and mortality related to GBS in adult males and nonpregnant females diagnosed with GBS bacteremia. All patients ≥14 years of age with GBS-positive blood cultures from January 1, 2015, until December 31, 2022, were included. Patient data such as age, sex, comorbidities, hospital ward, length of hospital stay, monomicrobial versus polymicrobial bloodstream infection, antimicrobials used for treatment, complications, whether an infectious disease specialist had seen them, and outcomes were extracted from the electronic health records. Results A total of 50 patients with GBS bacteremia met the inclusion criteria. The mean age of these patients was 57.0 years (SD = 16.0), and 27 (54%) were female. The 90-day mortality was 11 (22%). In total, 34 (68%) patients had a monomicrobial infection, and among those with polymicrobial infection, methicillin-resistant was the most common co-infection (56%, n = 9/16). The most common source of infection was SSTI and wound infection in 24 (48%) patients. Most patients had one or more comorbidities; the mean Charlson comorbidity index was 3.8 (SD = 2.4). The most prevalent comorbidity was diabetes mellitus in 35 (70%) patients. Of all variables analyzed, only age was significantly associated with mortality (p = 0.016), and age had a predictive value for mortality (p = 0.035). Conclusions In Saudi Arabia, as in other countries, GBS is an important pathogen, especially in older people, that should be considered when encountering a patient with bacteremia. In addition, in patients over 65 years old, GBS bacteremia carries a high risk for mortality.

References

Riefler 3rd J, Molavi A, Schwartz D, DiNubile M . Necrotizing fasciitis in adults due to group B streptococcus. Report of a case and review of the literature. Arch Intern Med. 1988; 148(3):727-9. View

Tyrrell G, Senzilet L, Spika J, Kertesz D, Alagaratnam M, Lovgren M . Invasive disease due to group B streptococcal infection in adults: results from a Canadian, population-based, active laboratory surveillance study--1996. Sentinel Health Unit Surveillance System Site Coordinators. J Infect Dis. 2000; 182(1):168-73. DOI: 10.1086/315699. View

Kothari N, Morin C, Glennen A, Jackson D, Harper J, Schrag S . Invasive group B streptococcal disease in the elderly, Minnesota, USA, 2003-2007. Emerg Infect Dis. 2009; 15(8):1279-81. PMC: 2815956. DOI: 10.3201/eid1508.081381. View

Huang P, Lee M, Yang C, Leu H . Group B streptococcal bacteremia in non-pregnant adults. J Microbiol Immunol Infect. 2006; 39(3):237-41. View

Harrison L, Ali A, Dwyer D, Libonati J, Reeves M, Elliott J . Relapsing invasive group B streptococcal infection in adults. Ann Intern Med. 1995; 123(6):421-7. DOI: 10.7326/0003-4819-123-6-199509150-00004. View

Tang G, Huang L, Zong Z . Impact of Infectious Disease Consultation on Clinical Management and Outcome of Patients with Bloodstream Infection: a Retrospective Cohort Study. Sci Rep. 2017; 7(1):12898. PMC: 5635120. DOI: 10.1038/s41598-017-13055-2. View

LERNER P, Gopalakrishna K, WOLINSKY E, McHENRY M, Tan J, Rosenthal M . Group B streptococcus (S. agalactiae) bacteremia in adults: analysis of 32 cases and review of the literature. Medicine (Baltimore). 1977; 56(6):457-73. DOI: 10.1097/00005792-197711000-00001. View

Phares C, Lynfield R, Farley M, Mohle-Boetani J, Harrison L, Petit S . Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA. 2008; 299(17):2056-65. DOI: 10.1001/jama.299.17.2056. View

Sendi P, Graber P, Johansson L, Norrby-Teglund A, Zimmerli W . Streptococcus agalactiae in relapsing cellulitis. Clin Infect Dis. 2007; 44(8):1141-2. DOI: 10.1086/513034. View

10.

Collin S, Shetty N, Lamagni T . Invasive Group B Streptococcus Infections in Adults, England, 2015-2016. Emerg Infect Dis. 2020; 26(6):1174-1181. PMC: 7258460. DOI: 10.3201/eid2606.191141. View

11.

Schwartz B, Schuchat A, Oxtoby M, Cochi S, Hightower A, Broome C . Invasive group B streptococcal disease in adults. A population-based study in metropolitan Atlanta. JAMA. 1991; 266(8):1112-4. View

12.

Gallagher P, Watanakunakorn C . Group B streptococcal bacteremia in a community teaching hospital. Am J Med. 1985; 78(5):795-800. DOI: 10.1016/0002-9343(85)90285-2. View

13.

Graux E, Hites M, Martiny D, Maillart E, Delforge M, Melin P . Invasive group B Streptococcus among non-pregnant adults in Brussels-Capital Region, 2005-2019. Eur J Clin Microbiol Infect Dis. 2020; 40(3):515-523. PMC: 7498195. DOI: 10.1007/s10096-020-04041-0. View

14.

Raabe V, Shane A . Group B (). Microbiol Spectr. 2019; 7(2). PMC: 6432937. DOI: 10.1128/microbiolspec.GPP3-0007-2018. View

15.

Ballard M, Schonheyder H, Knudsen J, Lyytikainen O, Dryden M, Kennedy K . The changing epidemiology of group B streptococcus bloodstream infection: a multi-national population-based assessment. Infect Dis (Lond). 2016; 48(5):386-91. DOI: 10.3109/23744235.2015.1131330. View

16.

Baraboutis I, Doris K, Papanikolaou K, Tsagalou E, Chatsiou K, Papathanasiou E . An outbreak of hemodialysis catheter-related bacteremia with sepsis caused by Streptococcus agalactiae in a hemodialysis unit. Int J Infect Dis. 2009; 14(5):e418-22. DOI: 10.1016/j.ijid.2009.06.029. View

17.

Goncalves B, Procter S, Paul P, Chandna J, Lewin A, Seedat F . Group B streptococcus infection during pregnancy and infancy: estimates of regional and global burden. Lancet Glob Health. 2022; 10(6):e807-e819. PMC: 9090904. DOI: 10.1016/S2214-109X(22)00093-6. View

18.

Eskandarian N, Neela V, Ismail Z, Puzi S, Hamat R, Desa M . Group B streptococcal bacteremia in a major teaching hospital in Malaysia: a case series of eighteen patients. Int J Infect Dis. 2013; 17(9):e777-80. DOI: 10.1016/j.ijid.2013.01.011. View

19.

Francois Watkins L, McGee L, Schrag S, Beall B, Jain J, Pondo T . Epidemiology of Invasive Group B Streptococcal Infections Among Nonpregnant Adults in the United States, 2008-2016. JAMA Intern Med. 2019; 179(4):479-488. PMC: 6450309. DOI: 10.1001/jamainternmed.2018.7269. View

20.

Phoompoung P, Pirogard N, Leelaporn A, Angkasekwinai N . Incidence of invasive Group B (iGBS) infections and the factors associated with iGBS mortality in adults during 2013-2017: a retrospective study at Thailand's largest national tertiary referral center. Ann Med. 2021; 53(1):715-721. PMC: 8158262. DOI: 10.1080/07853890.2021.1930138. View